Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy (2012)

  • Authors:
  • USP affiliated authors: ARRUDA NETO, JOAO DIAS DE TOLEDO - IF ; ENGLER, SILVYA STUCHI MARIA - FCF
  • USP Schools: IF; FCF
  • DOI: 10.1007/s00411-012-0416-y
  • Subjects: MELANOMA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00411-012-0416-y (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Radiation and Environmental Biophysics

    ISSN: 0301-634X

    Citescore - 2017: 1.74

    SJR - 2017: 0.64

    SNIP - 2017: 0.87


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FAIÃO-FLORES, Fernanda; COELHO, Paulo Rogério Pinto; CAMILLO, Maria Aparecida Pires; et al. Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy. Radiation and Environmental Biophysics, Berlin, v. 51, p. 319-329, 2012. DOI: 10.1007/s00411-012-0416-y.
    • APA

      Faião-Flores, F., Coelho, P. R. P., Camillo, M. A. P., Maria-Engler, S. S., Rici, R. E. G., Sarkis, J. E. S., et al. (2012). Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy. Radiation and Environmental Biophysics, 51, 319-329. doi:10.1007/s00411-012-0416-y
    • NLM

      Faião-Flores F, Coelho PRP, Camillo MAP, Maria-Engler SS, Rici REG, Sarkis JES, Maria DA, Arruda-Neto JD. Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy. Radiation and Environmental Biophysics. 2012 ;51 319-329.
    • Vancouver

      Faião-Flores F, Coelho PRP, Camillo MAP, Maria-Engler SS, Rici REG, Sarkis JES, Maria DA, Arruda-Neto JD. Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy. Radiation and Environmental Biophysics. 2012 ;51 319-329.

    Referências citadas na obra
    Barth RF (2003) A critical assessment of boron neutron capture therapy: an overview. J Neurooncol 62:1–5
    Barth RF, Matalka KZ, Bailey MQ, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK (1994) A nude rat model for neutron capture therapy of human intracerebral melanoma. Int J Radiat Oncol Biol Phys 28:1079–1088
    Cho HJ, Chun KJ, Park KW, Chung YS, Kim HR (2007) Determination of boron in a black mouse by prompt gamma activation analysis. J Radioanal Nuclear Chem 272:404–407
    Coderre JA, Morris GM (1999) The radiation biology of boron neutron capture therapy. Radiat Res 151:1–18
    Coderre JA, Glass JD, Fairchild RG, Micca PL, Joel DD (1990) Selective delivery of boron by the melanin precursor analogue boronophenylalanine in tumors other than melanoma. Cancer Res 50:138–141
    Coderre JA, Slatkin DN, Micca PL, Ciallella JR (1991) Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index. Radiat Res 128:177–185
    Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB (1994) Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30:643–652
    Coelho PRP, Hernandes AC, Siqueira PTD (2002) Neutron flux calculation in a BNCT research facility implemented in IEA-R1 reactor. In: 10th International Congress on Neutron Capture Therapy. Research and development in neutron capture therapy. Wolfgang S, Raymond M, Andrea W. Essen, Germany (Bologna), pp 197–201
    Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA (2005) Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Mol Pharm 2:151–156
    Faião-Flores F, Coelho PR, Arruda-Neto J, Maria DA (2011a) Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells. Appl Radiat Isot 69:1741–1744
    Faião-Flores F, Coelho PR, Muniz RO, Souza GS, Arruda-Neto J, Maria DA (2011b) Antitumor potential induction and free radicals production in melanoma cells by Boron Neutron Capture Therapy. Appl Radiat Isot 69:1748–1751
    Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW Jr, Lowe SW, Soengas MS (2005) Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65:6294–6304
    Fidler IJ (1975) Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35:218–224
    Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M et al (1994) Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 138:435–442
    Gautier EA, Roberti MJ, Gettar RT, Jiménez Rebagliati R, Batistoni DA (2007) Assessment of chemical purity of 10B-enriched p-boronophenylalanine by high-performance liquid chromatography coupled on-line with inductively coupled plasma optical emission spectrometry. Anal Bioanal Chem 388:499–503
    Gogas HJ, Kirkwood JM, Sondak VK (2009) Chemotherapy for metastatic melanoma: time for a change? Cancer 109:455–464
    Ichikawa H, Taniguchi E, Fujimoto T, Fukumori Y (2009) Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Appl Radiat Isot 67:S111–S114
    Ikeuchi I, Amano T (1978) A colorimetric determination of boron in biological materials. Chem Pharm Bull (Tokyo) 26:2619–2623
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
    Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN (2010) Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Lett 294:220–228
    Kamida A, Fujita Y, Kato I, Iwai S, Ono K, Suzuki M, Sakurai Y, Yura Y (2008) Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Int J Radiat Biol 84:191–199
    Kreimann EL, Miura M, Itoiz ME, Heber E, Garavaglia RN, Batistoni D, Rebagliati RJ, Roberti MJ, Micca PL, Coderre JA, Schwint AE (2003) Biodistribution of a carborane-containing porphyrin as a targeting agent for boron neutron capture therapy of oral cancer in the hamster cheek pouch. Arch Oral Biol 48:223–232
    Larrosa M, Tomás-Barberán FA, Espín JC (2003) Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem 51:4576–4584
    Mattiello EM, Ruiz HA, Silva IR, Sarkis JES (2011) Use of the HRICP-MS technique for the evaluation of boron isotopes in eucalitpus plants. Quím Nova 34:512–515
    Mendes PF, Xander P, Novaes e Brito RR, Mortara RA, Jasiulionis MG, Lopes JD (2008) A cell surface 230 kDa protein from murine melanoma involved with tumor malignancy. Cancer Lett 262:276–285
    Menéndez PR, Roth BM, Pereira MD, Casal MR, González SJ, Feld DB, Santa Cruz GA, Kessler J, Longhino J, Blaumann H, Jiménez Rebagliati R, Calzetta Larrieu OA, Fernández C, Nievas SI, Liberman SJ (2009) BNCT for skin melanoma in extremities: updated Argentine clinical results. Appl Radiat Isot 67:S50–S53
    Meyskens FL Jr (1981) Modulation of abnormal growth by retinoids: a clinical perspective of the biological phenomenon. Life Sci 28:2323–2327
    Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H (1989) Treatment of malignant melanoma by single thermal-neutron capture therapy with melanoma seeking B-10 compound. Lancet 2:388–389
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
    Probst TU (1999) Methods for boron analysis in boron neutron capture therapy (BNCT). A review. Fresenius J Anal Chem 364:391–403
    Sauerwein W (1993) Principles and history of neutron capture therapy. Strahlenther Onkol 169:1–6
    Soloway AH, Tjarks W, Barnum A, Rong FG, Barth RF, Codogni IM, Wilson JG (1998) The chemistry of neutron capture therapy. Chem Rev 98:1515–1562
    Suzuki M, Nagata K, Masunaga S, Kinashi Y, Sakurai Y, Maruhashi A, Ono K (2004) Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion. Appl Radiat Isot 61:933–937
    Trivillin VA, Heber EM, Rao M, Cantarelli MA, Itoiz ME, Nigg DW, Calzetta O, Blaumann H, Longhino J, Schwint AE (2008) Boron neutron capture therapy (BNCT) for the treatment of spontaneous nasal planum squamous cell carcinoma in felines. Radiat Environ Biophys 47:147–155
    Uchino H, Kanai Y, Kim DK, Wempe MF, Chairoungdua A, Morimoto E, Anders MW, Endou H (2002) Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 61:729–737
    Wittig A, Michel J, Moss RL, Stecher-Rasmussen F, Arlinghaus HF, Bendel P, Mauri PL, Altieri S, Hilger R, Salvadori PA, Menichetti L, Zamenhof R, Sauerwein WA (2008a) Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT). Crit Rev Oncol Hematol 68(1):66–90
    Wittig A, Malago M, Collette L, Huiskamp R, Buhrmann S, Nievaart V, Kaiser GM, Jockel KH, Schmid KW, Ortmann U, Sauerwein WA (2008b) Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). Int J Cancer 122:1164–1171
    Wittig A, Huiskamp R, Moss RL, Bet P, Kriegeskotte C, Scherag A, Hilken G, Sauerwein WA (2009) Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine. Radiat Res 172:493–499
    Yamamoto T, Nakai K, Matsumura A (2008) Boron neutron capture therapy for glioblastoma. Cancer Lett 262:143–152
    Zhao W, Entschladen F, Liu H, Niggemann B, Fang Q, Zaenker KS, Han R (2003) Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect Prev 27:67–75